...
search icon
ptn-img

Palatin Technologies Inc, Common Stock

PTN

ASQ

$19.09

-$2.03

(-9.61%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$35.96M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
60.37K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.20
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2 L
$72.5 H
$19.09

About Palatin Technologies Inc, Common Stock

Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey. more

Industry: BiotechnologySector: Health Care

Returns

Time FramePTNSectorS&P500
1-Week Return-22.62%0.14%-2.58%
1-Month Return40.78%0.79%1.71%
3-Month Return124.59%11.87%1.38%
6-Month Return154.53%15.42%12.4%
1-Year Return-49.09%11.99%14.51%
3-Year Return-87.68%14.37%75.98%
5-Year Return-96.53%36.1%81.23%
10-Year Return-97.69%118.17%234.79%

Financials

Jun '21Jun '22Jun '23Jun '24Jun '255YR TREND
Total Revenue(188.60K)1.47M4.85M4.49M-[{"date":"2021-06-30","value":-3.89,"profit":false},{"date":"2022-06-30","value":30.25,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":92.51,"profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Cost of Revenue147.84K217.53K418.47K97.64K258.92K[{"date":"2021-06-30","value":35.33,"profit":true},{"date":"2022-06-30","value":51.98,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":23.33,"profit":true},{"date":"2025-06-30","value":61.87,"profit":true}]
Gross Profit(336.44K)1.25M4.44M4.39M(258.92K)[{"date":"2021-06-30","value":-7.59,"profit":false},{"date":"2022-06-30","value":28.2,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":99.04,"profit":true},{"date":"2025-06-30","value":-5.84,"profit":false}]
Gross Margin178.39%85.19%91.38%97.83%-[{"date":"2021-06-30","value":100,"profit":true},{"date":"2022-06-30","value":47.75,"profit":true},{"date":"2023-06-30","value":51.22,"profit":true},{"date":"2024-06-30","value":54.84,"profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Operating Expenses33.05M37.84M37.92M26.89M22.45M[{"date":"2021-06-30","value":87.15,"profit":true},{"date":"2022-06-30","value":99.78,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":70.91,"profit":true},{"date":"2025-06-30","value":59.2,"profit":true}]
Operating Income(33.38M)(36.59M)(32.46M)(22.50M)(22.71M)[{"date":"2021-06-30","value":-3338410100,"profit":false},{"date":"2022-06-30","value":-3658844800,"profit":false},{"date":"2023-06-30","value":-3245888300,"profit":false},{"date":"2024-06-30","value":-2249612100,"profit":false},{"date":"2025-06-30","value":-2270783900,"profit":false}]
Total Non-Operating Income/Expense(235.83K)360.47K221.98K(7.26M)5.39M[{"date":"2021-06-30","value":-4.38,"profit":false},{"date":"2022-06-30","value":6.69,"profit":true},{"date":"2023-06-30","value":4.12,"profit":true},{"date":"2024-06-30","value":-134.75,"profit":false},{"date":"2025-06-30","value":100,"profit":true}]
Pre-Tax Income(33.60M)(36.20M)(32.22M)(29.74M)(17.31M)[{"date":"2021-06-30","value":-3359649500,"profit":false},{"date":"2022-06-30","value":-3619829900,"profit":false},{"date":"2023-06-30","value":-3221688600,"profit":false},{"date":"2024-06-30","value":-2973611300,"profit":false},{"date":"2025-06-30","value":-1730734900,"profit":false}]
Income Taxes(27.68K)(390.15K)(4.67M)(7.78M)-[{"date":"2021-06-30","value":-2768100,"profit":false},{"date":"2022-06-30","value":-39014900,"profit":false},{"date":"2023-06-30","value":-467499900,"profit":false},{"date":"2024-06-30","value":-778184400,"profit":false},{"date":"2025-06-30","value":"-","profit":true}]
Income After Taxes(33.57M)(35.81M)(27.54M)(21.95M)-[{"date":"2021-06-30","value":-3356881400,"profit":false},{"date":"2022-06-30","value":-3580815000,"profit":false},{"date":"2023-06-30","value":-2754188700,"profit":false},{"date":"2024-06-30","value":-2195426900,"profit":false},{"date":"2025-06-30","value":"-","profit":true}]
Income From Continuous Operations(33.60M)(36.20M)(27.54M)(29.74M)(17.31M)[{"date":"2021-06-30","value":-3359649500,"profit":false},{"date":"2022-06-30","value":-3619829900,"profit":false},{"date":"2023-06-30","value":-2754188700,"profit":false},{"date":"2024-06-30","value":-2973611300,"profit":false},{"date":"2025-06-30","value":-1730734900,"profit":false}]
Income From Discontinued Operations-----[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Net Income(33.57M)(35.81M)(27.54M)(29.74M)(17.31M)[{"date":"2021-06-30","value":-3356881400,"profit":false},{"date":"2022-06-30","value":-3580815000,"profit":false},{"date":"2023-06-30","value":-2754188700,"profit":false},{"date":"2024-06-30","value":-2973611300,"profit":false},{"date":"2025-06-30","value":-1730734900,"profit":false}]
EPS (Diluted)(3.75)(3.84)(2.53)(2.07)-[{"date":"2021-06-30","value":-375,"profit":false},{"date":"2022-06-30","value":-384,"profit":false},{"date":"2023-06-30","value":-253,"profit":false},{"date":"2024-06-30","value":-207,"profit":false},{"date":"2025-06-30","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

PTN
Cash Ratio 0.15
Current Ratio 1.02

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PTN
ROA (LTM) -106.84%
ROE (LTM) -623.20%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PTN
Debt Ratio Lower is generally better. Negative is bad. 0.95
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.05

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PTN
Trailing PE NM
Forward PE 62.89
P/S (TTM) 4.06
P/B 110.45
Price/FCF NM
EV/R 4.82
EV/Ebitda NM
PEG NM

FAQs

What is Palatin Technologies Inc share price today?

Palatin Technologies Inc (PTN) share price today is $19.09

Can Indians buy Palatin Technologies Inc shares?

Yes, Indians can buy shares of Palatin Technologies Inc (PTN) on Vested. To buy Palatin Technologies Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PTN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Palatin Technologies Inc be purchased?

Yes, you can purchase fractional shares of Palatin Technologies Inc (PTN) via the Vested app. You can start investing in Palatin Technologies Inc (PTN) with a minimum investment of $1.

How to invest in Palatin Technologies Inc shares from India?

You can invest in shares of Palatin Technologies Inc (PTN) via Vested in three simple steps:

  • Click on Sign Up or Invest in PTN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Palatin Technologies Inc shares
What is Palatin Technologies Inc 52-week high and low stock price?

The 52-week high price of Palatin Technologies Inc (PTN) is $72.5. The 52-week low price of Palatin Technologies Inc (PTN) is $2.

What is Palatin Technologies Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Palatin Technologies Inc (PTN) is 110.45

What is the Market Cap of Palatin Technologies Inc?

The market capitalization of Palatin Technologies Inc (PTN) is $35.96M

What is Palatin Technologies Inc’s stock symbol?

The stock symbol (or ticker) of Palatin Technologies Inc is PTN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top